Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin

NCT02649959 is registered in ClinicalTrials.gov with Curemark as lead sponsor.

NCT NCT02649959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02649959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Lead sponsor
Curemark
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 31, 2015
Completion date
January 31, 2028
Enrollment
405 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

autism